2.98
+0.03(+1.02%)
Currency In USD
| Previous Close | 2.95 |
| Open | 3 |
| Day High | 3.03 |
| Day Low | 2.95 |
| 52-Week High | 10.16 |
| 52-Week Low | 2.08 |
| Volume | 20,061 |
| Average Volume | 832,400 |
| Market Cap | 8.39M |
| PE | -1.38 |
| EPS | -2.16 |
| Moving Average 50 Days | 3.23 |
| Moving Average 200 Days | 3.76 |
| Change | 0.03 |
If you invested $1000 in Biomerica, Inc. (BMRA) 10 years ago, it would be worth $438.24 as of September 13, 2025 at a share price of $2.98. Whereas If you bought $1000 worth of Biomerica, Inc. (BMRA) shares 5 years ago, it would be worth $55.1 as of September 13, 2025 at a share price of $2.98.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Biomerica Launches AI-Backed inFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes
GlobeNewswire Inc.
Sep 09, 2025 12:08 PM GMT
New AI-enabled digital tool empowers patients to confidently manage IBS symptoms and avoid the trigger foods identified by inFoods® IBS testingIBS affects an estimated 40 million adults in the U.S. and hundreds of millions worldwide IRVINE, Calif., S
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Test for Home Use
GlobeNewswire Inc.
Sep 03, 2025 12:19 PM GMT
10-minute home test detects early kidney damage in diabetic and hypertensive patientsHypertension affects roughly one-third of adults in the UAEDiabetes impacts approximately one in four UAE nationals IRVINE, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE)
Biomerica Reports Fiscal 2025 Year End Results
GlobeNewswire Inc.
Aug 29, 2025 9:12 PM GMT
$1.3 Million in Operating Expense Reductions Achieved– Operating Loss Improves 19% Year-Over-YearResilient Portfolio Performance with International Sales Despite Global Economic UncertaintiesCash Used in Operating Activities Reduced to $3.8 Million v